Published in J Vasc Surg on September 01, 2005
Implementation of Vascular Care Team to Improve Medical Management of PAD Patients | NCT04400409
Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg (2009) 2.16
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg (2009) 1.35
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg (2007) 1.09
Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia. J Vasc Surg (2012) 1.07
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg (2006) 1.03
Mouse vein graft hemodynamic manipulations to enhance experimental utility. Am J Pathol (2011) 0.92
Disparities in vascular surgery: is it biology or environment? J Vasc Surg (2010) 0.90
Critical limb ischemia. Curr Treat Options Cardiovasc Med (2010) 0.88
Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population. J Vasc Surg (2014) 0.85
Acute reductions in mechanical wall strain precede the formation of intimal hyperplasia in a murine model of arterial occlusive disease. J Vasc Surg (2013) 0.83
Imaging stem cell therapy for the treatment of peripheral arterial disease. Curr Vasc Pharmacol (2012) 0.80
Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia. J Vasc Surg (2017) 0.78
Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia. Vasc Health Risk Manag (2014) 0.76
Prior contralateral amputation predicts worse outcomes for lower extremity bypasses performed in the intact limb. J Vasc Surg (2012) 0.75
Is atherectomy the best first-line therapy for limb salvage in patients with critical limb ischemia? Vasc Endovascular Surg (2009) 0.75
Influence of risk factors and comorbidities on the successful therapy and survival of patients with critical limb ischemia. Clujul Med (2013) 0.75
Infrainguinal open reconstruction: a review of surgical considerations and expected outcomes. Vasc Health Risk Manag (2017) 0.75
Antithrombotic treatment for peripheral arterial disease. Heart (2006) 0.75
Critical limb ischemia: advanced medical therapy. Methodist Debakey Cardiovasc J (2013) 0.75
Impact of critical limb ischemia on long-term cardiac mortality in diabetic patients undergoing percutaneous coronary revascularization. Diabetes Care (2013) 0.75
Using risk models to improve patient selection for high-risk vascular surgery. Scientifica (Cairo) (2012) 0.75
Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia. PLoS One (2015) 0.75
Surgeon, not institution, case volume is associated with limb outcomes after lower extremity bypass for critical limb ischemia in the Vascular Quality Initiative. J Vasc Surg (2017) 0.75
Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention. J Vasc Surg (2017) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care (1998) 18.69
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 16.32
Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65
Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med (1992) 8.94
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation (2004) 7.30
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med (1996) 7.26
Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol (2005) 5.30
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med (1999) 5.21
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol (1999) 3.36
Concern Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J (2001) 2.26
Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation (2003) 1.90
Statins and blood coagulation. Arterioscler Thromb Vasc Biol (2004) 1.89
Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med (2004) 1.82
Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA (2001) 1.34
Black-white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. J Clin Epidemiol (1995) 1.34
Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg (2001) 1.31
Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med (1997) 1.30
Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation (2002) 1.30
The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med (2003) 1.25
Continued adverse trends in coronary heart disease mortality among blacks, 1980-91. Public Health Rep (1995) 1.23
Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg (2004) 1.10
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg (2004) 1.03
A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg (2004) 1.00
Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg (2005) 0.98
Antithrombotic therapy in peripheral arterial occlusive disease. Chest (1998) 0.92
Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovasc Surg (2001) 0.90
Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis. Am J Med (2004) 0.83
Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg (2001) 0.80
Non-insulin dependent diabetes mellitus (NIDDM) in minority youth: research priorities and needs. Clin Pediatr (Phila) (1998) 0.79
Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med (2012) 20.79
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Lancet (2010) 10.79
Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med (2002) 7.35
Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. Radiology (2003) 3.59
Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg (2004) 3.41
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg (2006) 3.38
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology (2003) 2.64
Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18
Symptomatic venous thromboembolism after femoral vein harvest. J Vasc Surg (2012) 1.99
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg (2009) 1.81
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
Limitations in the cardiac risk reduction provided by coronary revascularization prior to elective vascular surgery. J Vasc Surg (2002) 1.56
Compliance with long-term surveillance recommendations following endovascular aneurysm repair or type B aortic dissection. J Vasc Surg (2013) 1.54
A fresh cadaver laboratory to conceptualize troublesome anatomic relationships in vascular surgery. J Vasc Surg (2011) 1.52
Efficacy of duplex ultrasound surveillance after infrainguinal vein bypass may be enhanced by identification of characteristics predictive of graft stenosis development. J Vasc Surg (2008) 1.49
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg (2008) 1.47
Predictors of healing and functional outcome following transmetatarsal amputations. Arch Surg (2011) 1.46
Ensuring vascular surgical training is on the right track. J Vasc Surg (2010) 1.45
Factors affecting career choice among the next generation of academic vascular surgeons. J Vasc Surg (2012) 1.44
Characterizing resolution of catheter-associated upper extremity deep venous thrombosis. J Vasc Surg (2009) 1.44
Magnetic resonance angiography minimizes need for arteriography after inadequate carotid duplex ultrasound scanning. J Vasc Surg (2003) 1.42
Outcomes of open operation for aortoiliac occlusive disease after failed endovascular therapy. Arch Surg (2012) 1.38
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.36
Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2004) 1.31
Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med (2006) 1.30
Vascular injuries associated with elective orthopedic procedures. Ann Vasc Surg (2003) 1.29
Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia. J Vasc Surg (2007) 1.28
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation (2011) 1.25
Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res (2005) 1.24
An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg (2005) 1.23
Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res (2004) 1.23
Improved outcomes in the recent management of secondary aortoenteric fistula. J Vasc Surg (2005) 1.22
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Vasc Med (2011) 1.19
Images in cardiovascular medicine. Serial high-spatial-resolution, multisequence magnetic resonance imaging studies identify fibrous cap rupture and penetrating ulcer into carotid atherosclerotic plaque. Circulation (2006) 1.13
Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arterioscler Thromb Vasc Biol (2011) 1.11
A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Arch Neurol (2010) 1.10
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg (2007) 1.09
Relationship of hemodialysis access to finger gangrene in patients with end-stage renal disease. J Vasc Surg (2002) 1.08
Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis--Society of Radiologists in Ultrasound consensus conference. Ultrasound Q (2003) 1.08
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg (2007) 1.07
Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res (2003) 1.05
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med (2011) 1.04
Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem (2005) 1.04
Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. J Vasc Surg (2003) 1.03
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg (2006) 1.03
The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients. J Vasc Surg (2003) 1.02
Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes (2011) 1.01
Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg (2002) 1.00
Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg (2012) 0.99
Percutaneous bioprosthetic venous valve: a long-term study in sheep. J Vasc Surg (2002) 0.99
Critical analysis of outcome determinants affecting repair of intact aneurysms involving the visceral aorta. Ann Vasc Surg (2005) 0.98
Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg (2005) 0.98
Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg (2007) 0.96
The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg (2007) 0.95
Evaluation of distributed practice schedules on retention of a newly acquired surgical skill: a randomized trial. Am J Surg (2011) 0.94
Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy. J Vasc Surg (2010) 0.94
Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells. Arterioscler Thromb Vasc Biol (2002) 0.94
Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol (2002) 0.94
Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation. J Vasc Surg (2004) 0.93
Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy. J Vasc Surg (2006) 0.93
Twentieth anniversary of American Vascular Association/Lifeline Foundation: a celebration. J Vasc Surg (2008) 0.93
Induction of vascular atrophy as a novel approach to treating restenosis. A review. J Vasc Surg (2007) 0.92
VASP increases hepatic fatty acid oxidation by activating AMPK in mice. Diabetes (2013) 0.92
Concomitant blockade of platelet-derived growth factor receptors alpha and beta induces intimal atrophy in baboon PTFE grafts. J Vasc Surg (2004) 0.91
Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. J Vasc Surg (2006) 0.91
Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections. J Vasc Surg (2006) 0.90
Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries. J Vasc Surg (2004) 0.90
Homocysteine and arterial disease. Experimental mechanisms. Vascul Pharmacol (2002) 0.90
Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem (2005) 0.90
Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg (2006) 0.90
Mesenteric duplex scanning. Perspect Vasc Surg Endovasc Ther (2006) 0.90
The comparative effectiveness of surgeons over interventionalists in endovascular repairs of abdominal aortic aneurysm. Ann Surg (2013) 0.89
Midfoot amputations expand limb salvage rates for diabetic foot infections. Ann Vasc Surg (2005) 0.89